Neuberger High Yield Strategies Fund Inc. (NHS)

Neuberger High Yield Strategies Fund Inc. (NHS) Financial Services Profile

Neuberger High Yield Strategies Fund Inc. (NHS) operates as a U.S.-based closed-end investment vehicle, established in 2003, primarily targeting high-yield debt instruments across global markets. It focuses on generating current income through diversified exposure to corporate bonds from sectors including automotive, telecommunications, and healthcare, managed by Neuberger Berman Investment Advisers LLC.

What Is the Investment Thesis for NHS?

The Neuberger High Yield Strategies Fund Inc. (NHS) presents an investment profile centered on its ability to generate high current income from a diversified portfolio of global high-yield debt securities. With a robust dividend yield of 17.16%, the fund offers significant income potential for investors. Its market capitalization stands at $0.20 billion, supported by a P/E ratio of 9.63 and a strong profit margin of 75.7%, indicating efficient management of its investment portfolio. A gross margin of 50.0% further highlights its operational effectiveness in the asset management sector. The fund's beta of 0.76 suggests lower volatility compared to the broader market, potentially offering a degree of capital preservation in turbulent periods. Key value drivers include the expertise of Neuberger Berman Investment Advisers LLC in credit analysis and active portfolio management, aiming to identify undervalued high-yield opportunities and manage credit risk. Growth catalysts are tied to the ongoing global demand for income-generating assets, particularly in a potentially lower-for-longer interest rate environment, and the expansion of the high-yield corporate bond market itself. However, investors must consider risks such as sensitivity to interest rate fluctuations, which can impact bond valuations, and credit spread widening, which could affect the market price of its underlying holdings. Monitoring the fund's net asset value (NAV) performance relative to its market price and the broader high-yield credit market is crucial for assessing its intrinsic value and market sentiment.

Based on FMP financials and quantitative analysis

NHS Key Highlights

• Market Capitalization: $0.20 billion, indicating its size within the closed-end fund landscape.
• Price-to-Earnings (P/E) Ratio: 9.63, reflecting investor valuation relative to its earnings.
• Profit Margin: 75.7%, demonstrating strong profitability from its investment activities.
• Dividend Yield: 17.16%, highlighting its primary objective of generating high current income for shareholders.
• Beta: 0.76, suggesting lower volatility compared to the overall market, potentially offering defensive characteristics.

Who Are NHS's Competitors?

NHS is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are NHS's Key Strengths?

• Strong dividend yield of 17.16% appealing to income-focused investors.
• Experienced management team from Neuberger Berman specializing in credit analysis.
• Diversified portfolio across numerous global sectors, mitigating concentration risk.
• Lower market volatility indicated by a Beta of 0.76.

What Are NHS's Weaknesses?

• Sensitivity to interest rate fluctuations, which can impact bond valuations.
• Exposure to credit spread widening, potentially affecting underlying asset prices.
• Market price can trade at a premium or discount to Net Asset Value (NAV), creating potential disconnects.
• Reliance on the performance of the high-yield corporate bond market.

What Could Drive NHS Stock Higher?

• **Ongoing: Favorable Credit Market Conditions**: A sustained period of stable economic growth and low corporate default rates could lead to tighter credit spreads in the high-yield market, potentially boosting the Net Asset Value (NAV) of NHS's holdings and supporting its income generation.
• **Upcoming: Stronger-than-expected Corporate Earnings**: Positive earnings reports from companies within NHS's diversified portfolio sectors (e.g., automotive, telecommunications, healthcare) could improve their credit profiles, leading to potential upgrades and increased demand for their bonds, benefiting the fund's valuation.
• **Ongoing: Continued Investor Demand for Income**: Persistent demand from investors for high-yielding assets, especially in a prolonged low-interest-rate environment, could support the fund's market price and potentially reduce any discount to NAV, enhancing shareholder returns.

What Are the Key Risks for NHS?

• Financial-distress signal — its Altman Z-Score of 1.18 sits in the distress zone (elevated bankruptcy risk).
• **Ongoing: Interest Rate Sensitivity**: As a fixed-income fund, NHS is inherently sensitive to changes in interest rates. A significant rise in benchmark rates could decrease the market value of its existing bond holdings, potentially impacting the fund's NAV and market price.
• **Potential: Credit Spread Widening**: An economic downturn or increased market uncertainty could lead to a widening of credit spreads in the high-yield market. This would increase the yield demanded by investors for high-yield bonds, causing their prices to fall and negatively affecting the fund's portfolio value.
• **Ongoing: Default Risk of Underlying Holdings**: Investing in high-yield debt inherently carries a higher risk of default by the issuing companies compared to investment-grade bonds. While diversified, a cluster of defaults within its portfolio could significantly impair the fund's capital and income generation capacity.
• **Potential: Regulatory Changes**: New or evolving regulations impacting the financial services industry, particularly those related to closed-end funds or high-yield debt markets, could impose additional compliance costs or restrict investment strategies, potentially affecting the fund's operational efficiency and profitability.

What Are the Growth Opportunities for NHS?

• **Sustained Demand for Income-Generating Assets**: The global financial landscape continues to see robust demand for investments that provide consistent income, particularly from an aging demographic and institutions seeking stable cash flows. NHS, with its explicit objective of generating high current income and a significant dividend yield, is well-positioned to attract capital from investors prioritizing distributions. The market for income-focused strategies is projected to remain strong, with global fixed income assets under management consistently growing, providing a fertile ground for funds like NHS to expand their investor base and potentially grow their asset base through secondary offerings or market appreciation of existing assets. This trend is expected to continue over the next 3-5 years.
• **Expansion of the Global High-Yield Market**: The high-yield corporate bond market has expanded significantly over the past two decades, driven by increased corporate issuance and a broader acceptance of non-investment grade debt as a legitimate asset class. As companies globally seek diverse funding sources, the universe of high-yield bonds available for investment continues to grow. NHS's strategy of investing in high-yield bonds across numerous global sectors positions it to capitalize on this expanding market. This provides a larger opportunity set for its management team to identify attractive credit opportunities, potentially enhancing portfolio diversification and income generation. This growth trajectory is anticipated to persist as global economic activity evolves.
• **Active Management Outperformance in Volatile Markets**: In periods of market volatility or economic uncertainty, active management can potentially outperform passive strategies, particularly in less efficient markets like high-yield debt. The experienced management team at Neuberger Berman Investment Advisers LLC specializes in credit analysis, which is crucial for navigating the complexities and risks inherent in high-yield securities. Their ability to conduct rigorous due diligence, manage credit risk, and dynamically adjust the portfolio can lead to superior risk-adjusted returns compared to broad market indices. This expertise becomes a significant competitive advantage, especially when credit spreads widen or specific sectors face headwinds, allowing the fund to potentially capitalize on mispricings.
• **Diversification Benefits for Investor Portfolios**: High-yield bonds, while carrying higher risk than investment-grade debt, can offer diversification benefits within a broader investment portfolio due to their lower correlation with other asset classes, including equities and traditional fixed income. For institutional investors and sophisticated individual investors, allocating a portion of their portfolio to a high-yield fund like NHS can enhance overall portfolio yield and potentially improve risk-adjusted returns. The fund's diversified exposure across various industries further reinforces this benefit, making it an attractive component for investors seeking to optimize their asset allocation strategies. This appeal is a long-term structural driver for the fund's relevance.
• **Potential for Capital Appreciation from Credit Quality Improvements**: While primarily focused on income, high-yield bonds can also offer capital appreciation if the credit quality of an issuing company improves, leading to a re-rating of its debt. Active management by NHS can identify companies with improving fundamentals or those on a path to investment-grade status (rising stars). As a company's financial health strengthens, its bond prices tend to rise, offering a secondary source of return beyond coupon payments. This opportunistic approach, combined with the fund's deep credit analysis capabilities, provides an additional avenue for value creation for shareholders, particularly during economic recoveries or periods of corporate deleveraging.

What Opportunities Does NHS Have?

• Sustained global demand for income-generating assets.
• Expansion of the high-yield corporate bond market, offering a broader investment universe.
• Potential for active management to outperform in volatile or less efficient credit markets.
• Capital appreciation from credit quality improvements in underlying holdings.

What Threats Does NHS Face?

• Rising interest rates could negatively impact bond prices and fund performance.
• Economic downturns leading to increased corporate defaults and credit downgrades.
• Increased competition from other high-yield funds, ETFs, and alternative income strategies.
• Regulatory changes impacting fixed income markets or closed-end funds.

What Are NHS's Competitive Advantages?

• **Experienced Management Team**: Leveraging the deep expertise in credit analysis and active portfolio management provided by Neuberger Berman Investment Advisers LLC.
• **Established Track Record**: Formed in 2003, the fund has a long operational history, demonstrating its ability to navigate various market cycles in the high-yield debt space.
• **Diversified Portfolio Strategy**: Investing across numerous global sectors and issuers helps mitigate specific credit risks and provides broader market exposure.
• **Closed-End Fund Structure**: Offers a fixed pool of capital, which can allow for more stable long-term investment strategies without the pressure of continuous redemptions seen in open-end funds.

What Does NHS Do?

The Neuberger High Yield Strategies Fund Inc., identified by its ticker symbol NHS, is a distinguished closed-end investment company primarily dedicated to the fixed income market. Established on July 28, 2003, by Neuberger Berman LLC, the fund operates under the expert oversight of Neuberger Berman Investment Advisers LLC, an entity renowned for its deep expertise in asset management. Headquartered in New York City, United States, NHS was initially known as the Neuberger Berman High Yield Strategies Fund, reflecting its foundational association with the broader Neuberger Berman group. Its core investment strategy revolves around allocating capital to debt instruments within global markets, with a specific and pronounced focus on high-yield bonds. These high-yield securities, often referred to as "junk bonds," are issued by companies across a broad spectrum of industries, signifying the fund's diversified approach to credit risk and income generation. The fund's portfolio is strategically constructed to include exposure to a wide array of sectors, mitigating concentration risk while seeking attractive yields. Key industries targeted for investment include automotive components and equipment, airlines, the broader automotive industry, electronics, healthcare services, packaging, integrated and service-based telecommunications, gaming, and natural gas distribution. This extensive sectoral diversification allows NHS to capitalize on various economic cycles and industry-specific opportunities within the high-yield debt landscape. As a closed-end fund, NHS issues a fixed number of shares that trade on an exchange, distinguishing it from open-end mutual funds which continuously issue and redeem shares. This structure can lead to its market price trading at a premium or discount to its net asset value (NAV), a characteristic closely monitored by investors. The fund's overarching objective is to generate high current income for its shareholders, making it an appealing option for investors seeking regular distributions from their fixed-income allocations. Its long operational history since 2003 underscores its established presence and experience in navigating the complexities of the global high-yield debt market.

What Products and Services Does NHS Offer?

• Operates as a closed-end investment company, meaning it has a fixed number of shares trading on an exchange.
• Primarily invests in high-yield debt securities, also known as "junk bonds," issued by corporations.
• Focuses on generating high current income for its shareholders through these debt investments.
• Allocates capital to debt instruments across diverse global markets.
• Invests in companies from a wide range of sectors, including automotive, airlines, electronics, healthcare services, packaging, telecommunications, gaming, and natural gas distribution.
• Managed by Neuberger Berman Investment Advisers LLC, leveraging their expertise in credit analysis and portfolio management.
• Seeks to provide investors with exposure to the high-yield corporate bond market.

How Does NHS Make Money?

• Generates revenue primarily through the income received from its portfolio of high-yield debt securities, such as interest payments.
• Aims to distribute this income to shareholders in the form of regular dividends, fulfilling its objective of high current income.
• Funds its operations and investment activities through its asset base, which is composed of capital raised from its initial public offering and subsequent market activities.
• Relies on the expertise of Neuberger Berman Investment Advisers LLC for active portfolio management, credit research, and risk mitigation.

What Industry Does NHS Operate In?

The Neuberger High Yield Strategies Fund Inc. (NHS) operates within the dynamic asset management industry, specifically targeting the high-yield fixed income segment. This sector is characterized by a continuous demand for income-generating assets, driven by both institutional and retail investors seeking returns beyond traditional investment vehicles. The global high-yield corporate bond market, which NHS primarily invests in, is a significant component of the broader fixed income universe, offering higher yields to compensate for increased credit risk compared to investment-grade bonds. Market trends include fluctuating interest rate environments, which directly impact bond valuations, and evolving credit cycles that influence default rates and credit spreads. NHS positions itself as a closed-end fund, a structure that provides investors with a fixed pool of assets managed by an experienced team, in contrast to open-end funds. Its competitive landscape includes other closed-end funds focused on high-yield debt, actively managed high-yield mutual funds, and passive high-yield exchange-traded funds (ETFs). NHS differentiates itself through the active management expertise of Neuberger Berman Investment Advisers LLC and its diversified exposure across numerous global sectors, aiming to deliver consistent high current income within this specialized market segment.

Who Are NHS's Key Customers?

• Individual investors seeking high current income and diversification within their fixed-income portfolios.
• Institutional investors, such as pension funds, endowments, and foundations, looking for specialized fixed-income exposure.
• Financial advisors and wealth managers who allocate client capital to income-generating closed-end funds.
• Investors willing to accept the higher credit risk associated with high-yield bonds in exchange for potentially greater income.

F-Score 4/9Financial Health

Neuberger High Yield Strategies Fund Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 1.18 places it in the distress zone, a signal of elevated financial risk.

ROE 9%Key Financial Metrics

Return on equity for Neuberger High Yield Strategies Fund Inc. stands at 8.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 5.9%, showing how much profit it generates from its asset base. NHS trades at a trailing price-to-earnings ratio of 9.63, below the Financial Services sector average of ~18x. Its free cash flow yield is 6.9%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 10.4%, the inverse of the P/E and a quick read on earnings relative to price.

NHS Valuation & Market Position

With a $194.91M market cap, Neuberger High Yield Strategies Fund Inc. sits in the micro-cap segment of the market. Relative to its peer group, NHS's quantitative score of 47/100 is below the peer average of 70/100.

NHS Financials

NHS Latest News

NHS Analyst Consensus

NHS MoonshotScore

Neuberger High Yield Strategies Fund Inc. Financial Services Stock: Key Questions Answered

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources